Hepatology

A study found that higher moderate-to-vigorous physical activity was associated with lower cardiovascular and all-cause mortality among individuals with metabolic dysfunction-associated steatotic liver disease.

A survival advantage linked to MASLD disappeared after matching, while BMI subgroup analyses suggested differing outcomes.

A retrospective study found that radiotherapy provided local control in unresectable extrahepatic bile duct cancer, while cholangitis, liver failure, and tumour bleeding contributed to at least 40% of deaths.

A multicentre study developed and validated a FIT model combining fibrin degradation products, serum iron, and tumour burden score to predict survival in patients with unresectable hepatocellular carcinoma receiving combined therapy.

Around 700 people received free liver health checks during UEG Week 2026 in Barcelona through the Love Your Liver initiative, highlighting the role of accessible screening, early detection and public health awareness in tackling liver disease.

GDF15 may protect against alcohol-associated liver disease by suppressing neutrophil glycolysis, inflammation, and liver injury.

A study of 9,761 adults linked high allostatic load and unhealthy behaviours to increased all-cause and cardiovascular mortality among participants with MASLD.

CT radiomics and tumour heterogeneity predict β-catenin expression in hepatocellular carcinoma.